403.85

INR
+16.65(+4.30%)
As of November 14, 2024 10:00:00 AM

Hikal Limited Share Price Information

24 hour Low and High

Low: 389.15
High: 410

All time High

703.09

Price Change 1h

+₹8.80 +2.23%

Price Change 1d

+₹8.80 +2.23%

Price Change 1w

+₹22.05 +5.78%

Hikal Limited Market Information

Exchange

NSE

Market Cap

4517.76 Cr

About Hikal Limited Share

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

2061

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Hikal Limited (NSE:HIKAL) Analysts Are Pretty Bullish On The Stock After Recent Results
  • Hikal Ltd and Windsor Machines hit a 52-week high despite fall in broader markets: Here’s why
  • Hikal Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Stocks to buy: DMart, Hikal, Century Textiles among 12 stocks that may rise 7-22% in the next 3-4 weeks, say analysts | Stock Market News
  • SDBL, Hikal among today's top stock picks by Jigar S Patel of Anand Rathi

FAQs

403.85

INR
+16.65(+4.30%)
As of November 14, 2024 10:00:00 AM

Hikal Limited Share Price Information

24 hour Low and High

Low: 389.15
High: 410

All time High

703.09

Price Change 1h

+₹8.80 +2.23%

Price Change 1d

+₹8.80 +2.23%

Price Change 1w

+₹22.05 +5.78%

Hikal Limited Market Information

Exchange

NSE

Market Cap

4517.76 Cr

About Hikal Limited Share

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

2061

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Hikal Limited (NSE:HIKAL) Analysts Are Pretty Bullish On The Stock After Recent Results
  • Hikal Ltd and Windsor Machines hit a 52-week high despite fall in broader markets: Here’s why
  • Hikal Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Stocks to buy: DMart, Hikal, Century Textiles among 12 stocks that may rise 7-22% in the next 3-4 weeks, say analysts | Stock Market News
  • SDBL, Hikal among today's top stock picks by Jigar S Patel of Anand Rathi

FAQs